We are a quantum physics-based, AI-powered drug R&D company with the mission to revolutionize drug discovery and development by improving the speed, scale, novelty and success rate.
Funding
Public
Current Stage
$364.76M
Recent Funding
$2.26B
Total Funding
Recent News
Innovative Chiral Building Blocks Solution Provider: Expanding Molecular Diversity from AiFChem
EIN Presswire
Fierce Pharma Asia—Astellas CEO’s 5-year plan; Takeda’s psoriasis win; RA’s China bridge program
FiercePharma
XtalPi enters $400m partnership for small molecule therapy for GPCR target
Pharmaceutical Technology